Immunaccel LLC

EntreMed is a clinical-stage pharmaceutical company that develops therapeutic candidates primarily for the treatment of cancer and inflammation. Its flagship drug candidate, Panzem, is in clinical trials for cancer, as well as in preclinical development for non-oncology indications. Another product, MKC-1, is a novel cell cycle inhibitor acquired through the 2006 acquisition of Miikana Therapeutics. EntreMed has expertise in angiogenesis, cell cycle regulation and inflammation-processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. EntreMed has headquarters in Rockville, Md., and its shares trade on the NASDAQ under the symbol ENMD.

Genecopoeia, located in Rockville, is a leading provider of innovative molecular and cellular biology products and services. With a commitment to excellence, Genecopoeia offers a wide range of solutions to meet the research needs of scientists and researchers worldwide. Generated from their website's infomation

US Biolab Corporation, located in the Washington Metropolitan area, is a global commercial biobank and human biospecimen contract research organization (CRO) dedicated to supporting biopharmaceutical and academic research. The company specializes in contract services for human sample validation studies, offering a comprehensive repository of over 300,000 high-quality biosamples and expertise in precision medicine and biomedical research projects. With experience in biomarker research and development, US Biolab has developed more than 300 types of tissue microarray and cell microarray products. Customization options for sample selection and tissue microarrays are available, enabling researchers to enhance their studies with guaranteed quality and tailored solutions. Generated from the website